SHMT2 and cancer: Existing research reports have demonstrated through molecular and cellular experiments that SHMT2 is involved in regulating signaling pathways such as cell cycle, redox, apoptosis, and ECM, which affect the proliferation and apoptosis of cancer cells (Zeng et al., 2021; Lee et al., 2014).